Product Details
A01315-19ON
eBook
Approximately 780 pages
1 volume bound
softcover
2019-06-27
Carswell

Can We Help?

If you need assistance, please call us at (416) 609-3800 (Toronto & international) / 1-800-387-5164 (toll free Canada & US).

We will be glad to assist you.

Canadian Patent Law Benchbook, Third Edition (ProView only)
By: Donald M. Cameron, B.A.Sc. (Eng. Sci.), M.A. Sc. (Aerospace), LL.B. , Bereskin & Parr
Availability: In Stock
Coming soon
$185.00
Description

An essential text for new members of the intellectual property law bar and those focusing their skills on the legal and business realities of patent law practice

Originally done as a resource for Canadian judges, Canadian Patent Law Benchbook provides a thorough analysis of Canadian patent law. Contributors use their considerable experience to bring their unique insights and provide clarity into Canadian patent law. In conjunction with Canadian Trade-Mark Law Benchbook, new and long-term members of the intellectual property bar and those seeking to refocus their skills on the fundamental legal and business realities of patent law practice.

New in this Edition

The Chapters have been thoroughly reviewed and commentary added covering the following issues:

  • AstraZeneca (2017, SCC) – its effect on patentability, validity attacks and the end of the “promise of the patent”
  • Patentable Subject Matter – including methods of medical treatment, isolated DNA sequences and computers
  • Obviousness – scope of prior art to be considered and “reasonably diligent searches”; evolution of “inventive concept”; “fair expectation of success” not the test in “obvious to try”; obviousness-type double patenting
  • Claim Construction – deference to the trier of fact; treatment of obvious errors; blinding expert witnesses; the non-essential element test of Free World and Whirlpool; the U.K. Actavis decision
  • Infringement – infringement by common design
  • Litigation Procedures – new proportionality for procedures in complex trials; confidentiality orders; expert witnesses and involvement of counsel in drafting expert reports
  • Patent Medicines (Notice of Compliance) Regulations –  new procedures for trials
  • Patents as a Business Asset – security interests and assignments

ProView eBook version is available through your web browser, or can be downloaded to your computer, tablet, or smartphone. See all available titles store.thomsonreuters.ca/ebook

About the Author

Donald M. Cameron, B.A.Sc. (Eng. Sci.), M.A. Sc. (Aerospace), LL.B., is a Partner at Bereskin & Parr LLP. His practice focuses on intellectual property litigation, particularly relating to patent, trade-mark, copyright, trade secrets law, and technology licences. He also advises clients on intellectual property portfolio strategies and the intellectual property aspects of technology licensing. He is certified as a Specialist by the Law Society of Upper Canada in Intellectual Property Law (Patents, Trademarks and Copyright) and Civil Litigation.

Don has participated in intellectual property law litigation involving a broad range of technologies and businesses including electromagnetic fields and induction, semiconductor chip fabrication, telecommunications, mechanical devices, bio-engineering, biotechnology, pharmaceuticals, and computer databases. He was senior trial counsel in Canada's first DNA patent trial and appeal as well as Canada’s first all-electronic IP trial.

Don is an Adjunct Professor of Law at the University of Toronto Faculty of Law and Osgoode Hall Law School at York University, teaching Patent and Trade Secret Law at both the undergraduate and graduate level.